Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer

Author： Yao Song  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.124, Iss.2, 2010-11, pp. : 433-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association between manganese superoxide dismutase gene polymorphism and breast cancer risk: A meta-analysis of 17,842 subjects

By            

Molecular Medicine Reports, Vol. 6, Iss. 4, 2012-01 ,pp. : 797-804

Spandidos Publications

Access to resources Recommend Favorite

Manganese superoxide dismutase polymorphism and risk of skin cancer (United States)

By Han Jiali   Colditz Graham   Hunter David  

Cancer Causes and Control, Vol. 18, Iss. 1, 2007-02 ,pp. : 79-89

Springer Publishing Company

Access to resources Recommend Favorite

Genetic variants in the vitamin D pathway and breast cancer disease-free survival

By Pande Mala  

Carcinogenesis, Vol. 34, Iss. 3, 2013-03 ,pp. : 587-594

Oxford University Press

Access to resources Recommend Favorite

LOH rather than genotypes of TP53 codon 72 is associated with disease-free survival in primary breast cancer

By Kyndi Marianne   Alsner Jan   Lotte Hansen Lise   Brandt Sørensen Flemming   Overgaard Jens  

Acta Oncologica, Vol. 45, Iss. 5, 2006-07 ,pp. : 602-609

Informa Healthcare

Access to resources Recommend Favorite

Manganese superoxide dismutase (MnSOD) polymorphism, α -tocopherol supplementation and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (Finland)

By Woodson K.  

Cancer Causes and Control, Vol. 14, Iss. 6, 2003-08 ,pp. : 513-518

Springer Publishing Company

Access to resources Recommend Favorite